MCLE — Medicale Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.78m
- $1.84m
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 0.002 | -0.032 | -0.046 | -0.038 |
Amortisation | ||||
Non-Cash Items | — | — | 0.007 | 0 |
Discontinued Operations | ||||
Unusual Items | ||||
Changes in Working Capital | -0.002 | 0.012 | 0.012 | 0.011 |
Change in Accounts Receivable | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Payable / Accrued Expenses | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 0 | -0.018 | -0.025 | -0.026 |
Other Investing Cash Flow Items | — | 0 | 0 | 0 |
Other Investing Cash Flow | ||||
Cash from Investing Activities | — | 0 | 0 | 0 |
Financing Cash Flow Items | 0.001 | 0.011 | 0.006 | 0.026 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Cash from Financing Activities | 0.001 | 0.036 | 0.006 | 0.026 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0 | 0.018 | -0.018 | 0 |